SHARI ASHTON: Open Payments
NPI 1912940263 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,650 in 179 payments from 19 companies in 2025. Trend: 2023 $7,395 · 2024 $7,027 · 2025 $5,650
Food & beverage: $4,070Speaker / faculty: $1,380Education: $200
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $1,738 |
| Janssen Biotech, Inc. | 49 | $1,056 |
| ABBVIE INC. | 26 | $494 |
| UCB, Inc. | 11 | $387 |
| E.R. Squibb & Sons, L.L.C. | 20 | $370 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $347 |
| Incyte Corporation | 10 | $295 |
| Arcutis Biotherapeutics, Inc. | 10 | $263 |
| Lilly USA, LLC | 8 | $171 |
| Amgen Inc. | 3 | $108 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Sotyktu, SKYRIZI, OPZELURA, Zoryve, ILUMYA.
Industry payments across FL — which companies pay providers there.
